Oncology Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
8 Lessons I’ve Learned as a Cancer Survivor
For most of my life I’ve lived by the belief that everything happens for a reason. The challenge is that I don’t always know what that reason is. That was certainly the case two years ago, when I was diagnosed with Leiomyosarcoma.It took a long time for me to learn what was making me sick. After searching for answers, an MRI revealed a large tumor deep in my abdomen. Following surgery to remove it, I learned that I had a rare and aggressive cancer that grows in the body’s soft tissues. Still, it...
June Social Media Round-Up—2025 Impact Report, ADA 2026, and More
School is out for the summer, but Pfizer colleagues are still hard at work. In June, we released our 2025 Impact Report, shared risks of fake medicines on World Anti-Counterfeit Day, and raised awareness of menstrual-related migraine and more.Pfizer has also been present at many conferences this past month—from ASCO and ADA to EHA and AHS 2026, and our leadership team has been highlighting the latest data that we’ve shared at these events. Meanwhile, CEO Albert Bourla joined the CNBC CEO Council...
A Prostate Cancer Survivor Shares the Importance of Early Detection—and Why Knowing Your History, Monitoring PSA and Talking to Your Doctor Matters
For years, senior oncology account specialist Dan Morgan has helped doctors understand what Pfizer medications can do for cancer patients. In 2024, the script flipped when he became a patient himself. Thanks to his work, Dan knew just how to advocate for his health by requesting blood tests and diagnostic exams, and his prostate cancer was detected early, before he even felt sick.Dan chose to work in oncology because of his family history. Back when he was in college, his dad had prostate cancer...
Living Longer with Cancer: Redefining What It Means to Survive
The sixth season of Science Will Win, Pfizer's award-winning podcast, focused on cancer. The six episodes explored the disease from every angle, from its rising incidence in younger populations to the precision medicine tools helping clinicians catch it earlier and treat it more effectively. Host Dr. Raven Baxter delved deep into each topic, interviewing doctors, scientists, researchers, and Pfizer colleagues to glean their insights and discuss the ongoing effort to conquer cancer.To further...
Multiple Myeloma: Shedding Light on a Rare but Complex Blood Cancer
Donna is more than a cancer patient: Donna is a wife, mother, grandmother, sister, and friend who has a full life outside of treatment. Her journey with multiple myeloma has revealed depths of resilience and strength that have long served her in all of those roles.“We have multiple myeloma…but that should not define us,” Donna shared in a recent video interview.It’s a message that Max Merz MD, MHBA, hematologist/oncologist and associate attending physician at Memorial Sloan Kettering Cancer...
May Social Media Round-Up—ASCO, Q1 2026 Results, and More
Summer’s approaching fast, but here at Pfizer the work doesn’t stop. So before you get outside to enjoy the warmer weather, catch up with the latest activity on our social channels.May has been chock full of highlights—from sharing the latest data across our cancer work at ASCO 2026 to a feature in TIME highlighting how we bring science from the lab to life, we’re offering looks behind the science of Pfizer’s research. Next, review Pfizer’s first quarter results, courtesy of CEO Albert Bourla...
Turning Silence Into Advocacy: Women Reshaping Cancer Conversations
The sixth season of Science Will Win, Pfizer’s award-winning podcast, focused on cancer, with each episode tackling a different aspect of the fight against the disease. Host Dr. Raven Baxter delved deep into a variety of topics within oncology, interviewing doctors, scientists, researchers, and Pfizer colleagues to glean their insights and discuss their efforts to eventually conquer cancer.To further the conversation, each of the five podcast episodes was accompanied by a full-length video...
For this Pfizer Scientist, Cancer Research is Personal
For Shuo Wang, cancer research isn’t just a job - it’s personal.Wang, a scientist in Pfizer’s oncology research unit, remembers when one of her close friends was diagnosed with stage four lung cancer shortly after giving birth to her second child. The experience happened early in her career, and deepened Wang’s determination to make a meaningful impact.Wang and her team spend their days planning experiments, analyzing data, and working together to help advance cancer treatments. Along with...
Lung Cancer: Real Risks, Common Myths, and Why Screening Matters
Can you name the top three cancer diagnoses affecting Americans? Did you guess breast (#1), prostate (#2), or colon (#4)? Those are good picks, but there’s another type of cancer that takes the number three spot: lung.1Lung cancer is the third-most diagnosed type of cancer in the country.2 Smoking remains the No. 1 risk factor for developing lung cancer,3 but 10 to 20 percent of lung cancers occur in people who have never smoked before (or who have smoked fewer than 100 cigarettes in their whole...
Pfizer’s New San Diego R&D Hub Accelerates the Next Wave of Cancer Innovation
A state-of-the-art campus designed to turn scientific ambition into breakthroughs for people with cancerFor more than two decades, Pfizer has pushed the boundaries of cancer care, developing medicines that have helped transform treatment for some of the world’s most challenging cancers. That progress continues to fuel an ambition to keep expanding what’s possible – an ambition brought to life in San Diego, where a new state-of-the-art campus has been purpose-built to help advance science and...
Podcast Highlights Pfizer Foundation’s Mission to Improve Breast Cancer Outcomes
For over 75 years, the Pfizer Foundation, a charitable organization, has worked toward the mission of helping build healthier communities around the world. By investing in locally led organizations and applying a community-centered approach, the Foundation aims to address today’s complex global health challenges, respond to urgent health needs, and empower Pfizer colleagues to make a positive impact where they live, work, and beyond.Launched in 2025, The Pfizer Foundation’s Action & Impact...
Making Progress Against Cancer - From Cancer Research to Prevention and Screening
Advances in cancer care often begin with incremental steps in the lab that, over time, have the power to drive transformative breakthroughs. That’s why scientists are working around the clock to develop potential treatments that could help patients live longer, healthier lives. At Pfizer, Sharsti Sandall is one of those scientists.An executive director in Pfizer’s oncology research division, Sandall leads the antibody drug conjugate (ADC) group, which is a targeted treatment that delivers cancer...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.